Mark D. Shepherd

1.2k total citations · 1 hit paper
11 papers, 928 citations indexed

About

Mark D. Shepherd is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics. According to data from OpenAlex, Mark D. Shepherd has authored 11 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Economics and Econometrics. Recurrent topics in Mark D. Shepherd's work include Diabetes Treatment and Management (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes Management and Research (4 papers). Mark D. Shepherd is often cited by papers focused on Diabetes Treatment and Management (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Diabetes Management and Research (4 papers). Mark D. Shepherd collaborates with scholars based in United States, United Kingdom and Germany. Mark D. Shepherd's co-authors include Chuji Wang, Om P. Ganda, Paul S. Jellinger, Donald A. Smith, Yehuda Handelsman, Adi Mehta, John A. Seibel, Helena W. Rodbard, Richard J. Auchus and H. Peter Chase and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and Mayo Clinic Proceedings.

In The Last Decade

Mark D. Shepherd

10 papers receiving 878 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

2012 407 citations Paul S. Jellinger, Donald A. Smith et al. Endocrine Practice profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Shepherd United States	8	394	293	169	120	101	11	928
Simon F.J. Clarke United Kingdom	13	152 0.4×	249 0.8×	117 0.7×	79 0.7×	135 1.3×	26	1000
Martha E. Lyon Canada	19	162 0.4×	201 0.7×	56 0.3×	26 0.2×	103 1.0×	60	950
Michael Conall Dennedy Ireland	20	334 0.8×	527 1.8×	51 0.3×	19 0.2×	79 0.8×	55	1.3k
William E. Owen United States	17	296 0.8×	87 0.3×	41 0.2×	18 0.1×	130 1.3×	40	929
Tingjie Zhang China	14	165 0.4×	101 0.3×	22 0.1×	61 0.5×	272 2.7×	33	909
Erna Lenters‐Westra Netherlands	13	459 1.2×	71 0.2×	36 0.2×	24 0.2×	107 1.1×	22	697
Steven F. Solga United States	19	494 1.3×	217 0.7×	462 2.7×	275 2.3×	108 1.1×	32	1.8k
Faranak Sharifi Iran	17	211 0.5×	58 0.2×	33 0.2×	26 0.2×	43 0.4×	41	843
C. Andrew Robinson United States	17	83 0.2×	123 0.4×	76 0.4×	18 0.1×	39 0.4×	43	840
Christine Collier Canada	18	199 0.5×	108 0.4×	39 0.2×	21 0.2×	220 2.2×	36	1.1k

Countries citing papers authored by Mark D. Shepherd

Since Specialization

Citations

This map shows the geographic impact of Mark D. Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Shepherd more than expected).

Fields of papers citing papers by Mark D. Shepherd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Shepherd. The network helps show where Mark D. Shepherd may publish in the future.

Co-authorship network of co-authors of Mark D. Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Shepherd. A scholar is included among the top collaborators of Mark D. Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Shepherd. Mark D. Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Shepherd, Mark D., Suzanne Novak, Kenneth A. Lawson, et al.. (2016). USE OF STATINS AND THE RISK OF INCIDENT DIABETES: A RETROSPECTIVE COHORT STUDY. Value in Health. 19(3). A199–A199.

Shepherd, Mark D., et al.. (2012). Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial). Current Medical Research and Opinion. 28(7). 1203–1211. 4 indexed citations

Jellinger, Paul S., Donald A. Smith, Adi Mehta, et al.. (2012). American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: Executive Summary. Endocrine Practice. 18(2). 269–293. 94 indexed citations

Jellinger, Paul S., Donald A. Smith, Adi Mehta, et al.. (2012). American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocrine Practice. 18. 1–78. 407 indexed citations breakdown →

Oyer, David S., et al.. (2011). Efficacy and Tolerability of Self-Titrated Biphasic Insulin Aspart 70/30 in Patients Aged >65 Years With Type 2 Diabetes: An Exploratory Post Hoc Subanalysis of the INITIATEplus Trial. Clinical Therapeutics. 33(7). 874–883. 9 indexed citations

Oyer, David S., et al.. (2009). A1c Control in a Primary Care Setting: Self-titrating an Insulin Analog Pre-mix (INITIATEplus Trial). The American Journal of Medicine. 122(11). 1043–1049. 36 indexed citations

Wang, Chuji, et al.. (2009). A Study on Breath Acetone in Diabetic Patients Using a Cavity Ringdown Breath Analyzer: Exploring Correlations of Breath Acetone With Blood Glucose and Glycohemoglobin A1C. IEEE Sensors Journal. 10(1). 54–63. 193 indexed citations

Shepherd, Mark D., et al.. (2002). Evaluation and Treatment of Erectile Dysfunction in Men With Diabetes Mellitus. Mayo Clinic Proceedings. 77(3). 276–282. 50 indexed citations

Chase, H. Peter, Tai M. Lockspeiser, Mark D. Shepherd, et al.. (2001). The Impact of the Diabetes Control and Complications Trial and Humalog Insulin on Glycohemoglobin Levels and Severe Hypoglycemia in Type 1 Diabetes. Diabetes Care. 24(3). 430–434. 83 indexed citations

10.

Carr‐Lopez, Sian M., et al.. (1999). Efficacy of three statins at lower maintenance doses. Clinical Therapeutics. 21(2). 331–339. 2 indexed citations

11.

Auchus, Richard J., et al.. (1997). Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?. Clinical Endocrinology. 46(1). 21–27. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact